167 related articles for article (PubMed ID: 35982893)
1. P2RY13 Exacerbates Intestinal Inflammation by Damaging the Intestinal Mucosal Barrier via Activating IL-6/STAT3 Pathway.
Wu X; Wei S; Chen M; Li J; Wei Y; Zhang J; Dong W
Int J Biol Sci; 2022; 18(13):5056-5069. PubMed ID: 35982893
[TBL] [Abstract][Full Text] [Related]
2. 2'-Hydroxycinnamaldehyde Alleviates Intestinal Inflammation by Attenuating Intestinal Mucosal Barrier Damage Via Directly Inhibiting STAT3.
Chen M; Wei S; Wu X; Xiang Z; Li X; He H; Liao F; Wang X; Zhang J; Yu B; Dong W
Inflamm Bowel Dis; 2024 Jun; 30(6):992-1008. PubMed ID: 38422244
[TBL] [Abstract][Full Text] [Related]
3. Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis.
Li X; Li Q; Xiong B; Chen H; Wang X; Zhang D
Pharmacol Res; 2022 Sep; 183():106368. PubMed ID: 35905891
[TBL] [Abstract][Full Text] [Related]
4. 2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation.
Li J; Wei Y; Liu C; Guo X; Liu Z; Zhang L; Bao S; Wu X; Wang X; Zhang J; Dong W
Clin Nutr; 2024 Feb; 43(2):380-394. PubMed ID: 38150914
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis.
Lee MJ; Lee JK; Choi JW; Lee CS; Sim JH; Cho CH; Lee KH; Cho IH; Chung MH; Kim HR; Ye SK
PLoS One; 2012; 7(9):e38801. PubMed ID: 22962574
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation.
Chen Y; Sun L; Li D; Yin X; Shang G; Diao T; Shi L
Turk J Gastroenterol; 2022 Sep; 33(9):731-742. PubMed ID: 35946886
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation.
Wang Z; Li R; Tan J; Peng L; Wang P; Liu J; Xiong H; Jiang B; Chen Y
Inflamm Bowel Dis; 2015 Aug; 21(8):1894-907. PubMed ID: 25970544
[TBL] [Abstract][Full Text] [Related]
8. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis.
Chu XQ; Wang J; Chen GX; Zhang GQ; Zhang DY; Cai YY
Pathol Res Pract; 2018 Jan; 214(1):151-162. PubMed ID: 29129493
[TBL] [Abstract][Full Text] [Related]
10. Cryptotanshinone ameliorates dextran sulfate sodium-induced murine acute and chronic ulcerative colitis via suppressing STAT3 activation and Th17 cell differentiation.
Fan LM; Zhang YQ; Chen YP; Chen LL; Xu WH; Nan LH; Xu W; Lu B; Wang Y; Chu KD; Zhang JP
Int Immunopharmacol; 2022 Jul; 108():108894. PubMed ID: 35729830
[TBL] [Abstract][Full Text] [Related]
11.
Wang J; Su L; Zhang L; Zeng J; Chen Q; Deng R; Wang Z; Kuang W; Jin X; Gui S; Xu Y; Lu X
J Zhejiang Univ Sci B; 2022 Jun; 23(6):481-501. PubMed ID: 35686527
[TBL] [Abstract][Full Text] [Related]
12. The function of Sphingosine-1-phosphate receptor 2 (S1PR2) in maintaining intestinal barrier and inducing ulcerative colitis.
Chen T; Gu K; Lin R; Liu Y; Shan Y
Bioengineered; 2022 May; 13(5):13703-13717. PubMed ID: 35707833
[TBL] [Abstract][Full Text] [Related]
13. Baitouweng decoction alleviates dextran sulfate sodium-induced ulcerative colitis by regulating intestinal microbiota and the IL-6/STAT3 signaling pathway.
Xuan-Qing CHEN; Xiang-Yu LV; Shi-Jia LIU
J Ethnopharmacol; 2021 Jan; 265():113357. PubMed ID: 32891820
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
Zheng R; Ma J; Wang D; Dong W; Wang S; Liu T; Xie R; Liu L; Wang B; Cao H
Mediators Inflamm; 2018; 2018():1562010. PubMed ID: 30498394
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
Yu LZ; Wang HY; Yang SP; Yuan ZP; Xu FY; Sun C; Shi RH
World J Gastroenterol; 2013 May; 19(17):2638-49. PubMed ID: 23674871
[TBL] [Abstract][Full Text] [Related]
16. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
[TBL] [Abstract][Full Text] [Related]
17. Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice.
Willson TA; Jurickova I; Collins M; Denson LA
Inflamm Bowel Dis; 2013 Mar; 19(3):512-25. PubMed ID: 23429443
[TBL] [Abstract][Full Text] [Related]
18. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.
Pickert G; Neufert C; Leppkes M; Zheng Y; Wittkopf N; Warntjen M; Lehr HA; Hirth S; Weigmann B; Wirtz S; Ouyang W; Neurath MF; Becker C
J Exp Med; 2009 Jul; 206(7):1465-72. PubMed ID: 19564350
[TBL] [Abstract][Full Text] [Related]
19. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
20. Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways.
Lee H; Son YS; Lee MO; Ryu JW; Park K; Kwon O; Jung KB; Kim K; Ryu TY; Baek A; Kim J; Jung CR; Ryu CM; Park YJ; Han TS; Kim DS; Cho HS; Son MY
Theranostics; 2020; 10(11):5048-5063. PubMed ID: 32308767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
